Nimesulide associated fulminant hepatic failure

Pharmacoepidemiology and Drug Safety

Volumn 17, Issue 11, 2008, Pages 1108-1112

  Walker, Sarah L ^a   Kennedy, Fionnuala ^a   Niamh, Nolan ^a   McCormick, P Aiden ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Drug induced liver injury; Hepatitis; Hepatotoxicity; Liver failure; Liver transplant

Indexed keywords

HERBACEOUS AGENT; NIMESULIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EXPOSURE; EMERGENCY SURGERY; FEMALE; HEPATITIS C; HUMAN; IRELAND; LIVER FAILURE; LIVER FUNCTION TEST; LIVER GRAFT; LIVER INJURY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; TREATMENT DURATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HUMANS; IRELAND; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SULFONAMIDES; YOUNG ADULT;

EID: 57649170598     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1665     Document Type: Article

References (26)

1. Dastis SN, Rahier J, Lerut J, Geubel AP. Liver transplantation for nonsteroidal anti-inflammatory drug-induced liver failure: nimesulide as the first implicated compound. Eur J Gastroenterol Hepatol 2007; 19: 919-922.
2. McCormick PA, Kennedy F, Curry M, Traynor O. COX 2 inhibitor and fulminant hepatic failure. Lancet 1999; 353: 40-41.
3. Bessone F, Colombato L, Pasamonti ME, Godoy A, et al. Nimesulide: clinical and histological evidences of severe hepatotoxicity. J Hepatol 2001; 34 (Suppl 1): 46.
4. Bessone F, Fay F, Vorobioff J, Passamonti ME, Godoy A, Tanno H. Nimesulide hepatotoxicity. Hepatology 1997; 26: 483A.
5. van Steenbergen W, Peeters P, De Bondt J, et al. Nimesulide-induced acute hepatitis: evidence from six cases. J. Hepatol 1998; 29: 135-141.
6. Merlani G, Fox M, Ochen HP, et al. Fatal hepatotoxicity secondary to nimesulide. Eur J Clin Pharmacol 2001; 57: 321-326.
7. Ozgur O, Hacihasanoglu A, Karti SS, Ovali E. Nimesulide-induced fulminant hepatitis. Turk J Gastroenterol 2003; 14: 208-210.
8. Polimeni G, Salvo F, Cutroneo P, Morreale I, Patirzio Caputi A. Adverse reactions induced by NSAID's and antibacterials: analysis of spontaneous reports from the Sicilian regional database. Drug Safety 2006; 29: 449-459.
9. Rodrigo L, de Francisco R, Perez-Pariente JM, et al. Nimesulide-induced severe hemolytic anemia and acute liver failure leading to liver transplantation. Scand J Gastroenterol 2002; 37: 1341-1343.
10. Andrade RJ, Lucena MI, Fernandez MC, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 2005; 129: 512-521.
11. Weiss P, Mouallem M, bruck R, et al. Nimesulide-induced hepatitis and acute liver failure. Isr Med Assoc J 1999; 1: 89-91.
12. Schattner A, Sokolovskaya N, Cohen J. Fatal hepatitis and renal failure during treatment with nimesulide. J. Intern Med 2000; 247: 153-155.
13. Andrade RJ, Lucena MI, Fernandez C, Gonzalez M. Fatal hepatitis associated with nimesulide. J. Hepatol 2000; 32: 174.
14. Sabate M, Ibanez L, Perez E, et al. Risk of acute liver injury associated with the use of drugs: a multicentre population survey. Aliment Pharmacol Ther 2007; 25: 1401-1409.
15. Tan HH, Ong WM, Lai SH, Chow WC. Nimesulide-induced hepatotoxicity and fatal hepatic failure. Singapore Med J 2007; 48: 582-585.
16. Traversa G, Bianchi C, Da Cas R, Abraha I, Menniti-Ippolito F, Veneqoni M. Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs. Br Med J 2003; 327: 18-22.
17. Gatti S, Bertazzoli M. Evaluation of isolated case reports on hepatotoxicity. Eur J Clin Pharmacol 2002; 57: 919-920.
18. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-245.
19. Danan G, Benichou C. Causality assessment of adverse reactions to drugs-1. A. novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J. Clin Epidemiol 1993; 46: 1323-1330.
20. Benichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs-II. An original model for validation of drug causality assessment methods: case reports with positive rechallange. J. Clin Epidemiol 1993; 46: 1331-1336.
21. Farci P, Alter HJ, Shimoda A, et al. Hepatitis C virus-associated fulminant hepatic failure. N. Engl J Med 1996; 335: 631-634.
22. Chu CM, Yeh CT, Liaw YF. Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus. Gut 1999; 45: 613-617.
23. Kramer JR, Giardano TP, Souchek J, El-serag HB. Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era. J. Hepatol 2005; 42: 309-314.
24. Esposti ED, Liverani S, Capone A, Russo P. Liver injury associated with nimesulide: is it a truly negligible event? Br Med J 2003; Available from: URL: http://www.bmj.com/cgi/eletters/327/7405/18.
25. Graham DJ. Telithromycin and acute liver failure. N. Engl J Med 2006; 355: 2260-2261.
26. Sgro C, Clinard F, Ouazir K, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 2002; 36: 451-455.